Skip to main content
    P

    Palisade Bio Inc (PALI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.03
    -0.09 (-8.04%)

    Market Cap: $201.01M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Palisade Bio Inc (PALI) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Palisade Bio (PALI) is expected to report earnings on Mar 18, 2027. In the quarter ended Sep 30, 2026, Palisade Bio reported EPS of -$0.07, below the -$0.06 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    50%(12/24)
    Avg Surprise
    +16.69%

    Upcoming Estimates

    Reports Mar 18, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.07
    Range-$0.10 - -$0.05
    12 analysts
    Revenue Consensus
    N/A
    RangeN/A
    10 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.07
    Range-$0.08 - -$0.05
    4 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.07-11.5%
    60d ago-$0.07-11.5%
    30d ago-$0.07-8.7%
    7d ago-$0.07-8.7%
    Current-$0.07
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts

    Next Report

    PALI has an expected report date of Mar 18, 2027.

    Earnings History

    Of the 24 quarters below that had an estimate, PALI beat 12, missed 11 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2022, when EPS landed 366.26% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.07-$0.06-$0.07 - -$0.05-16.67%MissN/A81 up, 5 downNov 10, 2026N/A
    Jun 30, 2026-$0.05-$0.05-$0.07 - -$0.040.00%In lineN/A72 up, 1 downAug 10, 2026$500000
    Mar 31, 2026-$0.05-$0.04-$0.06 - -$0.01-14.50%MissN/A60 up, 1 downMay 12, 2026N/A
    Dec 31, 2025-$0.06-$0.03-$0.05 - -$0.01-97.17%MissN/A61 up, 1 downMar 23, 2026N/A
    Sep 30, 2025-$0.38-$0.27-$0.47 - -$0.03-40.74%MissN/A31 up, 1 downNov 10, 2025N/A
    Jun 30, 2025-$0.58-$0.56-$0.62 - -$0.48-3.57%MissN/A30 up, 0 downAug 11, 2025N/A
    Mar 31, 2025-$0.47-$0.81-$0.84 - -$0.78+41.98%BeatN/A20 up, 0 downMay 12, 2025N/A
    Dec 31, 2024-$0.69-$1.99-$2.76 - -$0.81+65.27%BeatN/A30 up, 2 downMar 24, 2025$4000
    Sep 30, 2024-$2.32-$3.35-$3.63 - -$3.07+30.75%BeatN/A20 up, 0 downNov 12, 2024N/A
    Jun 30, 2024-$3.32-$2.93-$3.11 - -$2.75-13.31%MissN/A20 up, 0 downAug 12, 2024N/A
    Mar 31, 2024-$4.59-$3.75N/A-22.40%MissN/A10 up, 0 downMay 13, 2024N/A
    Dec 31, 2023-$6.45-$5.17-$5.40 - -$4.95-24.76%Miss-199.7%20 up, 0 downMar 26, 2024N/A
    Sep 30, 2023-$7.35-$6.15N/A-19.51%MissN/A20 up, 0 downNov 9, 2023N/A
    Jun 30, 2023-$7.95-$6.82-$7.50 - -$6.15-16.57%MissN/A20 up, 0 downAug 11, 2023N/A
    Mar 31, 2023-$8.10-$9.90-$11.84 - -$9.90+18.18%BeatN/A20 up, 0 downMay 12, 2023$250000
    Dec 31, 2022$6.47-$2.43-$2.47 - -$2.40+366.26%BeatN/A20 up, 0 downMar 22, 2023N/A
    Sep 30, 2022-$61.06-$67.50N/A+9.54%BeatN/A20 up, 0 downNov 14, 2022N/A
    Jun 30, 2022-$90.00-$217.50N/A+58.62%BeatN/A10 up, 0 downAug 15, 2022N/A
    Mar 31, 2022-$13.00-$14.00-$14.50 - -$13.50+7.14%BeatN/A20 up, 0 downMay 13, 2022N/A
    Dec 31, 2021-$165.75-$180.00N/A+7.92%BeatN/A20 up, 0 downMar 16, 2022N/A
    Sep 30, 2021-$187.27-$270.00N/A+30.64%BeatN/A10 up, 0 downNov 15, 2021N/A
    Jun 30, 2021-$3.53N/AN/AN/AN/AN/AN/AN/AAug 24, 2021N/A
    Mar 31, 2021-$4.39N/AN/AN/AN/AN/AN/AN/AMay 14, 2021N/A
    Dec 31, 2020-$0.25N/AN/AN/AN/AN/AN/AN/AMar 22, 2021N/A
    Sep 30, 2020-$4.39N/AN/AN/AN/AN/AN/AN/ANov 10, 2020N/A
    Jun 30, 2020-$4.39N/AN/AN/AN/AN/AN/AN/AAug 13, 2020N/A
    Mar 31, 2020-$4.39N/AN/AN/AN/AN/AN/AN/AMay 15, 2020$6020
    Dec 31, 2019-$4.39N/AN/AN/AN/AN/AN/AN/AMar 27, 2020$2500
    Sep 30, 2019-$4.39N/AN/AN/AN/AN/AN/AN/ANov 14, 2019$2500
    Jun 30, 2019-$4.39N/AN/AN/AN/AN/AN/AN/AAug 14, 2019$7894
    Mar 31, 2019-$0.22N/AN/AN/AN/AN/AN/AN/AMay 14, 2019$2500
    Dec 31, 2018-$0.22N/AN/AN/AN/AN/AN/AN/AMar 22, 2019$2500
    Sep 30, 2018-$0.12N/AN/AN/AN/AN/AN/AN/ANov 14, 2018$2500
    Jun 30, 2018-$0.80N/AN/AN/AN/AN/AN/AN/AAug 13, 2018$252500
    Mar 31, 2018-$2.80N/AN/AN/AN/AN/AN/AN/AApr 2, 2018$2500
    Dec 31, 2017-$0.18N/AN/AN/AN/AN/AN/AN/AMar 22, 2018$252500
    Sep 30, 2017-$0.18N/AN/AN/AN/AN/AN/AN/ANov 8, 2017$2500
    Jun 30, 2017-$2,160.00-$4,380.00N/A+50.68%BeatN/AN/AN/AAug 8, 2017$2500
    Mar 31, 2017-$2,580.00-$3,120.00N/A+17.31%BeatN/AN/AN/AMay 10, 2017$2500
    Dec 31, 2016-$4,200.00-$3,120.00N/A-34.62%MissN/AN/AN/AMar 23, 2017$8746
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.49, after -$10.92 the year before. It was -$16,680.00 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.49N/A
    Dec 31, 2024-$10.92N/A
    Dec 31, 2023-$29.85N/A
    Dec 31, 2022-$157.59N/A
    Dec 31, 2021-$360.94N/A
    Dec 31, 2020-$13.42N/A
    Dec 31, 2019-$13.39N/A
    Dec 31, 2018-$3.94N/A
    Dec 31, 2017-$4,740.36N/A
    Dec 31, 2016-$16,680.00N/A

    Frequently Asked Questions About PALI

    When is Palisade Bio's next earnings date?

    Palisade Bio's next earnings report is expected for Mar 18, 2027.

    Did PALI beat earnings estimates last quarter?

    No. Palisade Bio reported EPS of -$0.07 for the quarter ended Sep 30, 2026, below the -$0.06 estimate by 16.67%.

    What EPS do analysts expect from PALI next quarter?

    The consensus EPS estimate for Palisade Bio for the quarter ending Dec 31, 2026 is -$0.07 from 12 analysts, with estimates from -$0.10 to -$0.05.

    How often does PALI beat earnings estimates?

    Palisade Bio beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -8.18%.